Skip to main content

Articles

Page 8 of 69

  1. Surgeries for idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children are complex because of the high risk of inflammatory postoperative complications. There is no consensus about t...

    Authors: Julie Molimard, Christine Pajot, Priscille Olle, Alexandre Belot, Pierre Quartier, Florence Uettwiller, Chloé Couret, Valentine Coste, Camille Costet, Bahram Bodaghi, Pascal Dureau, Marion Bailhache and Pascal Pillet
    Citation: Pediatric Rheumatology 2021 19:139
    Content type: Research article Published on:

  2. This case study documents the first familial case of Blau syndrome (BS) in Palestine characterized with mutation in CARD15/NOD2.

    Authors: Salam Iriqat, Mohammed Abu Safieh, Manuel Fatouleh and Abdulsalam Alkaiyat
    Citation: Pediatric Rheumatology 2021 19:138
    Content type: Case Report Published on:

  3. Consensus treatment plans have been developed for induction therapy of newly diagnosed proliferative lupus nephritis (LN) in childhood-onset systemic lupus erythematosus. However, patients who do not respond t...

    Authors: Mileka Gilbert, Beatrice Goilav, Joyce J. Hsu, Paul J. Nietert, Esra Meidan, Annabelle Chua, Stacy P. Ardoin, Scott E. Wenderfer, Emily von Scheven and Natasha M. Ruth
    Citation: Pediatric Rheumatology 2021 19:137
    Content type: Research article Published on:

  4. The importance of developmentally appropriate transitional care in young people with juvenile-onset rheumatic and musculoskeletal disease is well recognised. The Paediatric Rheumatology European Society (PReS)...

    Authors: Janet E. McDonagh, Rachel Tattersall, Jacqui Clinch, Joanne Swan, Helen E. Foster and Liza McCann
    Citation: Pediatric Rheumatology 2021 19:136
    Content type: Review Published on:

  5. Juvenile idiopathic arthritis (JIA) is the most common paediatric rheumatological disorder and is classified by subtype according to International League of Associations for Rheumatology criteria. Depending on...

    Authors: Lina N. Zaripova, Angela Midgley, Stephen E. Christmas, Michael W. Beresford, Eileen M. Baildam and Rachel A. Oldershaw
    Citation: Pediatric Rheumatology 2021 19:135
    Content type: Review Published on:

  6. Juvenile idiopathic arthritis (JIA), is the most common pediatric rheumatologic disorder with unknown etiology. Currently, no population-based data are available regarding the distribution of categories and fr...

    Authors: Sezgin Sahin, Ceyhun Acari, Hafize Emine Sonmez, Fatma Zehra Kilic, Erdal Sag, Hatice Adiguzel Dundar, Amra Adrovic, Selcan Demir, Kenan Barut, Yelda Bilginer, Betul Sozeri, Erbil Unsal, Seza Ozen and Ozgur Kasapcopur
    Citation: Pediatric Rheumatology 2021 19:134
    Content type: Research article Published on:

  9. We aimed to characterize etanercept (ETN) use in juvenile idiopathic arthritis (JIA) patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.

    Authors: Timothy Beukelman, Aimee Lougee, Roland A. Matsouaka, David Collier, Dax G. Rumsey, Jennifer Schenfeld, Scott Stryker, Marinka Twilt and Yukiko Kimura
    Citation: Pediatric Rheumatology 2021 19:131
    Content type: Research article Published on:

  10. Juvenile idiopathic arthritis constitutes a significant cause of disability and quality of life impairment in pediatric and adult patients. The aim of this study was to ascertain clinical remission (CR) and su...

    Authors: Mireia Castillo-Vilella, Nuria Giménez, Jose Luis Tandaipan, Salvador Quintana and Consuelo Modesto
    Citation: Pediatric Rheumatology 2021 19:130
    Content type: Research article Published on:

  11. The curriculum for professionals working in paediatric rheumatology should include pain but it is unclear to what extent this currently occurs. The aim of this study was to identify pain-related curriculum con...

    Authors: Rebecca Rachael Lee, Janet E. McDonagh, Mark Connelly, Sarah Peters and Lis Cordingley
    Citation: Pediatric Rheumatology 2021 19:129
    Content type: Research article Published on:

  12. Juvenile-onset Fibromyalgia (JFM) is a chronic pain condition characterized by widespread musculoskeletal pain, fatigue, sleep difficulties, mood concerns, and other associated symptoms. Although diagnosed in ...

    Authors: Morgan Daffin, Mary K. Lynch-Milder, Robert C. Gibler, Caitlin Murray, Carly M. Green and Susmita Kashikar-Zuck
    Citation: Pediatric Rheumatology 2021 19:128
    Content type: Research article Published on:

  13. High-intensity glucocorticoid regimens are commonly used to induce and maintain remission in Juvenile Dermatomyositis but are associated with several adverse side-effects. Evidence-based treatment guidelines f...

    Authors: Amir B. Orandi, Lampros Fotis, Jamie Lai, Hallie Morris, Andrew J. White, Anthony R. French and Kevin W. Baszis
    Citation: Pediatric Rheumatology 2021 19:127
    Content type: Research article Published on:

  14. Mutations along PSTPIP1 gene are associated to two specific conditions, PAPA syndrome and PAMI syndrome, both autoinflammatory disorders associated to disturbances in cytoskeleton formation. Immunological aspe...

    Authors: Leonardo Oliveira Mendonça, Maria Teresa Terreri, Fabiane Mitie Osaku, Samar Freschi Barros, Karen Francine Köhler, Alex Isidoro Prado, Myrthes Toledo Barros, Jorge Kalil and Fabio Fernandes Morato Castro
    Citation: Pediatric Rheumatology 2021 19:126
    Content type: Research article Published on:

  17. Based on the recently developed ChRonic nonbacterial Osteomyelitis MRI Scoring tool (CROMRIS), we developed a radiological activity index (RAI-CROMRIS) to obtain a quantification of the overall bone involvemen...

    Authors: Martina Capponi, Denise Pires Marafon, Flaminia Rivosecchi, Yongdong Zhao, Manuela Pardeo, Virginia Messia, Laura Tanturri de Horatio, Paolo Tomà, Fabrizio De Benedetti and Antonella Insalaco
    Citation: Pediatric Rheumatology 2021 19:123
    Content type: Research article Published on:

  18. The impact of social determinants of health on children with polyarticular juvenile idiopathic arthritis (pJIA) is poorly understood. Prompt initiation of treatment for pJIA is important to prevent disease mor...

    Authors: Nayimisha Balmuri, William Daniel Soulsby, Victoria Cooley, Linda Gerber, Erica Lawson, Susan Goodman, Karen Onel and Bella Mehta
    Citation: Pediatric Rheumatology 2021 19:122
    Content type: Research article Published on:

  19. Mendelian susceptibility to mycobacterial disease (MSMD) is an inborn error of immunity, resulting in susceptibility to weakly virulent mycobacteria and other intramacrophagic pathogens. Rheumatologic manifest...

    Authors: Niusha Sharifinejad, Seyed Alireza Mahdaviani, Mahnaz Jamee, Zahra Daneshmandi, Afshin Moniri, Majid Marjani, Payam Tabarsi, Parisa Farnia, Mahsa Rekabi, Mazdak Fallahi, Seyedeh Atefeh Hashemimoghaddam, Masoumeh Mohkam, Jacinta Bustamante, Jean-Laurent Casanova, Davood Mansouri and Ali Akbar Velayati
    Citation: Pediatric Rheumatology 2021 19:121
    Content type: Case Report Published on:

  22. High-dose glucocorticoids (GC) remain the primary therapy to induce remission in Juvenile Dermatomyositis (JDM). Studies of the natural history of GC associated weight gain in children are very limited, especi...

    Authors: Amer Khojah, Victoria Liu, Gabrielle Morgan, Richard M. Shore and Lauren M. Pachman
    Citation: Pediatric Rheumatology 2021 19:118
    Content type: Short Report Published on:

  23. To describe a case of pediatric sarcoidosis which initially presented as papillary conjunctivitis before manifesting as bilateral lacrimal gland swelling without other known systemic involvement.

    Authors: Margaret S. Powell, Ashley W. Cross, Jared Tallo, Edward W. Cheeseman and Mileka R. Gilbert
    Citation: Pediatric Rheumatology 2021 19:117
    Content type: Case Report Published on:

  24. Despite being at high risk for depression, patients with childhood-onset systemic lupus erythematosus (c-SLE) are infrequently and inconsistently screened for depression by their pediatric rheumatologists. We ...

    Authors: Evan Mulvihill, Rebecca Furru, Alana Goldstein-Leever, Kyla Driest, Stephanie Lemle, Darby MacDonald, Emily Frost and Vidya Sivaraman
    Citation: Pediatric Rheumatology 2021 19:116
    Content type: Research article Published on:

    The Correction to this article has been published in Pediatric Rheumatology 2021 19:133

  25. Authors: Francesco Baldo, Michela Brena, Simone Carbogno, Francesca Minoia, Stefano Lanni, Sophie Guez, Antonella Petaccia, Carlo Agostoni, Rolando Cimaz and Giovanni Filocamo
    Citation: Pediatric Rheumatology 2021 19:115
    Content type: Correction Published on:

    The original article was published in Pediatric Rheumatology 2021 19:80

  26. Respiratory conditions are the leading cause of hospitalization and death in children with Trisomy 21 (T21). Diffuse alveolar hemorrhage (DAH) occurs at higher frequency in children with T21; yet, it is not wi...

    Authors: Jessica L. Bloom, Benjamin Frank, Jason P. Weinman, Csaba Galambos, Sean T. O’Leary, Deborah R. Liptzin and Robert C. Fuhlbrigge
    Citation: Pediatric Rheumatology 2021 19:114
    Content type: Case Report Published on:

  30. Despite the commonality of adolescent knee pain, there are no tools to support medical doctors to correctly diagnose knee pain. This study aimed to develop and evaluate a support tool for diagnosing the most c...

    Authors: Clara Guldhammer, Sinead Holden, Marina Elmelund Sørensen, Jens Lykkegaard Olesen, Martin Bach Jensen and Michael Skovdal Rathleff
    Citation: Pediatric Rheumatology 2021 19:110
    Content type: Research article Published on:

  31. Glucocorticoid exposure is a significant driver of morbidity in children with systemic juvenile idiopathic arthritis (sJIA). We determined the effect of early initiation of biologic therapy (IL-1 or IL-6 inhib...

    Authors: Rosemary G. Peterson, Rui Xiao, Hannah Katcoff, Brian T. Fisher and Pamela F. Weiss
    Citation: Pediatric Rheumatology 2021 19:109
    Content type: Research article Published on:

  32. Immunosuppressive drugs, incomplete vaccine coverage, immune system dysregulation might be factors of a low level of anti-vaccine antibodies in JIA patients. The study aimed to evaluate vaccine coverage, post-...

    Authors: Mikhail M. Kostik, Natalia A. Lubimova, Irina V. Fridman, Olga V. Goleva and Susanna M. Kharit
    Citation: Pediatric Rheumatology 2021 19:108
    Content type: Research article Published on:

  33. High-dose intravenous immunoglobulin (IVIG) is the mainstay of treatment for Kawasaki disease (KD). Usually, 2 g/kg of IVIG is administered over 10–24 h, depending on the institution or physician, but the asso...

    Authors: Saori Fukui, Mitsuru Seki, Takaomi Minami, Kazuhiko Kotani, Kensuke Oka, Akiko Yokomizo, Daisuke Matsubara, Tomoyuki Sato, Yasuyuki Nozaki, Mari Saito, Yutaka Kikuchi, Kenji Miyamoto, Yukifumi Monden and Takanori Yamagata
    Citation: Pediatric Rheumatology 2021 19:107
    Content type: Research article Published on:

  34. Recognition of temporomandibular joint (TMJ) involvement in children with juvenile idiopathic arthritis (JIA) has gained increasing attention in the past decade. The clinical assessment of mandibular range of ...

    Authors: Willemijn F. C. de Sonnaville, Caroline M. Speksnijder, Nicolaas P. A. Zuithoff, Daan R. C. Verkouteren, Nico W. Wulffraat, Michel H. Steenks and Antoine J. W. P. Rosenberg
    Citation: Pediatric Rheumatology 2021 19:106
    Content type: Research article Published on:

  35. Chronic illness, such as juvenile idiopathic arthritis (JIA), appears to have an impact on the mental health of children and adolescents. The aim of this study was to explore the incidence of mental and behavi...

    Authors: Minna S. Kyllönen, Hanna Ebeling, Hannu Kautiainen, Kari Puolakka and Paula Vähäsalo
    Citation: Pediatric Rheumatology 2021 19:105
    Content type: Research article Published on:

  36. H syndrome (HS) is a rare autoinflammatory disease caused by a mutation in the solute carrier family 29, member 3 (SCL29A3) gene. It has a variable clinical presentation and little phenotype-genotype correlati...

    Authors: Laura Ventura-Espejo, Inés Gracia-Darder, Silvia Escribá-Bori, Eva Regina Amador-González, Ana Martín-Santiago and Jan Ramakers
    Citation: Pediatric Rheumatology 2021 19:104
    Content type: Case Report Published on:

  37. Dermatomyositis with positive anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody has a distinct phenotype associated with small hand joint arthritis, mucocutaneous ulceration, palmar papules ...

    Authors: Tsz-Wing Yeung, Kai-Ning Cheong, Yu-Lung Lau and Kei-Chiu Niko Tse
    Citation: Pediatric Rheumatology 2021 19:103
    Content type: Case Report Published on:

  38. The inflammatory process in juvenile idiopathic arthritis (JIA) involves both the innate and the adaptive immune system. The turnover and activity of neutrophil granulocytes may be reflected by proteins secret...

    Authors: Malin Backlund, Per Venge and Lillemor Berntson
    Citation: Pediatric Rheumatology 2021 19:102
    Content type: Research article Published on:

  39. Most childhood-onset rheumatic diseases are chronic health conditions, which need long-term care throughout adulthood. A well-organized transition care is challenging and patient assessment of transition skill...

    Authors: Sirinthip Kittivisuit, Butsabong Lerkvaleekul, Sirisucha Soponkanaporn, Pintip Ngamjanyaporn and Soamarat Vilaiyuk
    Citation: Pediatric Rheumatology 2021 19:101
    Content type: Research article Published on:

  40. Dermatomyositis is an inflammatory muscle disease caused by immune-mediated muscle injury, and central core disease (CCD) is a congenital myopathy associated with disturbed intracellular calcium homeostasis an...

    Authors: Min Jung Kim, Mi Hyeon Kim, Sung-Hye Park and Yeong Wook Song
    Citation: Pediatric Rheumatology 2021 19:100
    Content type: Case Report Published on:

  41. Primary cutaneous mucinosis are a heterogeneous group of diseases characterized by the deposition of glycosaminoglycans in the dermis and the follicles. These diseases are rare in children therefore their diag...

    Authors: Cristina Morreale, Dario Bleidl, Angela Rita Sementa and Clara Malattia
    Citation: Pediatric Rheumatology 2021 19:99
    Content type: Case Report Published on:

  42. Subcutaneous anakinra is an interleukin-1 inhibitor used to treat juvenile idiopathic arthritis. Recent reports suggest anakinra can be a valuable addition to the treatment of COVID-19 associated cytokine stor...

    Authors: Omkar Phadke, Kelly Rouster-Stevens, Helen Giannopoulos, Shanmuganathan Chandrakasan and Sampath Prahalad
    Citation: Pediatric Rheumatology 2021 19:98
    Content type: Short Report Published on:

  43. Physical activity (PA) patterns in children with juvenile idiopathic arthritis (JIA) over time are not well described. The aim of this study was to describe associations of physical activity (PA) with disease ...

    Authors: Liane D. Heale, Kristin M. Houghton, Elham Rezaei, Adam D. G. Baxter-Jones, Susan M. Tupper, Nazeem Muhajarine, Susanne M. Benseler, Gilles Boire, David A. Cabral, Sarah Campillo, Gaëlle Chédeville, Anne-Laure Chetaille, Paul Dancey, Ciaran Duffy, Karen Watanabe Duffy, Janet Ellsworth…
    Citation: Pediatric Rheumatology 2021 19:97
    Content type: Research article Published on:

  44. Coronary artery lesions (CALs) are the most severe complication of Kawasaki disease (KD). Approximately 9–20% of the patients with KD develop CAL despite receiving regular treatment (intravenous immunoglobulin...

    Authors: Xuting Zhang, Yuee He, Yiping Shao, Biyao Hang, Zhipeng Xu and Maoping Chu
    Citation: Pediatric Rheumatology 2021 19:96
    Content type: Research article Published on:

  45. Here, we investigated the predictive efficiency of a newly developed model based on single nucleotide polymorphisms (SNPs) and laboratory data for intravenous immunoglobulin (IVIG) resistance in Kawasaki disea...

    Authors: Li Meng, Zhen Zhen, Qian Jiang, Xiao-hui Li, Yue Yuan, Wei Yao, Ming-ming Zhang, Ai-jie Li and Lin Shi
    Citation: Pediatric Rheumatology 2021 19:95
    Content type: Research article Published on:

  46. There are few reports of COVID-19 in pediatric patients with rheumatic diseases. This study describes the clinical presentation and outcomes of COVID-19 in this population.

    Authors: D. Sofia Villacis-Nunez, Christina A. Rostad, Kelly Rouster-Stevens, Arezou Khosroshahi, Shanmuganathan Chandrakasan and Sampath Prahalad
    Citation: Pediatric Rheumatology 2021 19:94
    Content type: Research article Published on:

  48. Juvenile idiopathic inflammatory myopathies (JIIMs) is a group of autoimmune disorders, including juvenile dermatomyositis (JDM), juvenile polymyositis (JPM) and overlap myositis, that are characterized by pro...

    Authors: Megan Mariko Perron, Natalia Vasquez-Canizares, Gabriel Tarshish and Dawn M. Wahezi
    Citation: Pediatric Rheumatology 2021 19:92
    Content type: Research article Published on:

  49. Juvenile idiopathic arthritis (JIA) is a heterogeneous group of disorders, including all forms of arthritis, which develops in children who are less than 16 years old. This study aimed to evaluate the clinical...

    Authors: Raed M. Alzyoud, Motasem O. Alsuweiti, Heba Q. Almaaitah, Bushra N. Aladaileh, Mohammad K. Alnoubani and Adel M. Alwahadneh
    Citation: Pediatric Rheumatology 2021 19:90
    Content type: Research article Published on:

  50. Although, preliminary reports of Severe Acute Respiratory Syndrome (SARS)-CoV-2 infection suggest that the infection causes a less severe illness in children, there is now growing evidence of other rare or eve...

    Authors: Reza Sinaei, Sara Pezeshki, Saeedeh Parvaresh, Roya Sinaei, Reza Shiari, Mehrnoush Hassas Yeganeh, Nasrin Bazargn and Nava Gharaei
    Citation: Pediatric Rheumatology 2021 19:89
    Content type: Case Report Published on:

Official journal of

  • New Content Item
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    3.0 - 5-year Impact Factor
    1.035 - SNIP (Source Normalized Impact per Paper)
    0.732 - SJR (SCImago Journal Rank)

    2023 Speed
    18 days submission to first editorial decision for all manuscripts (Median)
    94 days submission to accept (Median)

    2023 Usage 
    1,095,144 downloads
    691 Altmetric mentions

Pediatric Rheumatology

ISSN: 1546-0096